FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1668367055> ?p ?o ?g. }

• W1668367055 endingPage "7208" @default.
• W1668367055 startingPage "7202" @default.
• W1668367055 abstract "Abstract Glucosamine, a natural glucose derivative and an essential component of glycoproteins and proteoglycans, has been safely used to relieve osteoarthritis in humans. Recent studies have shown that glucosamine also possesses immunosuppressive properties and is effective in prolonging graft survival in mice. Whether this reagent is effective in human multiple sclerosis (MS), an inflammatory demyelination in the CNS, is not known. We thus investigated the therapeutic effect of glucosamine on experimental autoimmune encephalomyelitis (EAE), an animal model of MS. We demonstrated that oral, i.p., or i.v. administration of glucosamine significantly suppressed acute EAE, with reduced CNS inflammation and demyelination. A significant, albeit not strong, blockade of Th1 response and an up-regulation of Th2 cytokines (IL-5 and IL-10) are observed in the splenocytes of glucosamine-treated mice. Glucosamine also regulates IL-5 and IL-10 in vitro. As glucosamine is able to effectively suppress acute EAE, has low or absent toxicity, and has been safely used in humans orally, our study suggests a potential use for this drug alone or in combination with other disease-modifying immunotherapies to enhance their efficacy and reduce their doses in MS and possibly other autoimmune disorders. Furthermore, because glucosamine functions not simply as an immunosuppressant, but as a mild immunomodulator, administration of glucosamine provides a novel immunoregulatory approach for autoimmune disorders." @default.
• W1668367055 created "2016-06-24" @default.
• W1668367055 creator A5008925941 @default.
• W1668367055 creator A5029904155 @default.
• W1668367055 creator A5031836301 @default.
• W1668367055 creator A5069388655 @default.
• W1668367055 date "2005-12-01" @default.
• W1668367055 modified "2023-10-15" @default.
• W1668367055 title "Glucosamine Abrogates the Acute Phase of Experimental Autoimmune Encephalomyelitis by Induction of Th2 Response" @default.
• W1668367055 cites W1505371021 @default.
• W1668367055 cites W1522211409 @default.
• W1668367055 cites W1527404918 @default.
• W1668367055 cites W1552686264 @default.
• W1668367055 cites W1678513801 @default.
• W1668367055 cites W1854485154 @default.
• W1668367055 cites W1914553247 @default.
• W1668367055 cites W1979993194 @default.
• W1668367055 cites W1980857453 @default.
• W1668367055 cites W1982500633 @default.
• W1668367055 cites W1982634625 @default.
• W1668367055 cites W1982675296 @default.
• W1668367055 cites W1986007604 @default.
• W1668367055 cites W1990176415 @default.
• W1668367055 cites W1993076646 @default.
• W1668367055 cites W1994437674 @default.
• W1668367055 cites W1998776723 @default.
• W1668367055 cites W1999044236 @default.
• W1668367055 cites W2006249161 @default.
• W1668367055 cites W2007452107 @default.
• W1668367055 cites W2012433400 @default.
• W1668367055 cites W2045322838 @default.
• W1668367055 cites W2046713296 @default.
• W1668367055 cites W2058505385 @default.
• W1668367055 cites W2060844736 @default.
• W1668367055 cites W2063033721 @default.
• W1668367055 cites W2078297463 @default.
• W1668367055 cites W2078728822 @default.
• W1668367055 cites W2088369230 @default.
• W1668367055 cites W2090197666 @default.
• W1668367055 cites W2095259741 @default.
• W1668367055 cites W2106115061 @default.
• W1668367055 cites W2109429374 @default.
• W1668367055 cites W2113279573 @default.
• W1668367055 cites W2116633290 @default.
• W1668367055 cites W2117595099 @default.
• W1668367055 cites W2125595025 @default.
• W1668367055 cites W2132063944 @default.
• W1668367055 cites W2153862724 @default.
• W1668367055 cites W2163682172 @default.
• W1668367055 cites W2167736293 @default.
• W1668367055 cites W4211261427 @default.
• W1668367055 cites W88063777 @default.
• W1668367055 doi "https://doi.org/10.4049/jimmunol.175.11.7202" @default.
• W1668367055 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16301624" @default.
• W1668367055 hasPublicationYear "2005" @default.
• W1668367055 type Work @default.
• W1668367055 sameAs 1668367055 @default.
• W1668367055 citedByCount "55" @default.
• W1668367055 countsByYear W16683670552012 @default.
• W1668367055 countsByYear W16683670552013 @default.
• W1668367055 countsByYear W16683670552014 @default.
• W1668367055 countsByYear W16683670552015 @default.
• W1668367055 countsByYear W16683670552016 @default.
• W1668367055 countsByYear W16683670552017 @default.
• W1668367055 countsByYear W16683670552018 @default.
• W1668367055 countsByYear W16683670552019 @default.
• W1668367055 countsByYear W16683670552020 @default.
• W1668367055 countsByYear W16683670552022 @default.
• W1668367055 countsByYear W16683670552023 @default.
• W1668367055 crossrefType "journal-article" @default.
• W1668367055 hasAuthorship W1668367055A5008925941 @default.
• W1668367055 hasAuthorship W1668367055A5029904155 @default.
• W1668367055 hasAuthorship W1668367055A5031836301 @default.
• W1668367055 hasAuthorship W1668367055A5069388655 @default.
• W1668367055 hasBestOaLocation W16683670551 @default.
• W1668367055 hasConcept C159654299 @default.
• W1668367055 hasConcept C185592680 @default.
• W1668367055 hasConcept C203014093 @default.
• W1668367055 hasConcept C2776914184 @default.
• W1668367055 hasConcept C2777899865 @default.
• W1668367055 hasConcept C2778125326 @default.
• W1668367055 hasConcept C2778486448 @default.
• W1668367055 hasConcept C2779075594 @default.
• W1668367055 hasConcept C2780640218 @default.
• W1668367055 hasConcept C55493867 @default.
• W1668367055 hasConcept C71924100 @default.
• W1668367055 hasConcept C98274493 @default.
• W1668367055 hasConceptScore W1668367055C159654299 @default.
• W1668367055 hasConceptScore W1668367055C185592680 @default.
• W1668367055 hasConceptScore W1668367055C203014093 @default.
• W1668367055 hasConceptScore W1668367055C2776914184 @default.
• W1668367055 hasConceptScore W1668367055C2777899865 @default.
• W1668367055 hasConceptScore W1668367055C2778125326 @default.
• W1668367055 hasConceptScore W1668367055C2778486448 @default.
• W1668367055 hasConceptScore W1668367055C2779075594 @default.
• W1668367055 hasConceptScore W1668367055C2780640218 @default.
• W1668367055 hasConceptScore W1668367055C55493867 @default.
• W1668367055 hasConceptScore W1668367055C71924100 @default.

• next